| Bioactivity | 6-Methyl-9-(β-D-xylofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 6-Methyl-9-(β-D-xylofuranosyl)purine |
| CAS | 16006-65-8 |
| Formula | C11H14N4O4 |
| Molar Mass | 266.25 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
6-Methyl-9-(β-D-xylofuranosyl)purine
CAS: 16006-65-8 F: C11H14N4O4 W: 266.25
6-Methyl-9-(β-D-xylofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor acti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.